Healthcare & Life Sciences
Cullinan Therapeutics
United Stateswww.linkedin.com/company/cullinantx/
alivepre-ipo
pre-ipo
Stage
1
Investors
About
Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing disease-modifying T cell engagers for autoimmune diseases and cancer, with a focus on oncology and immune-directed therapies.
Explore Cullinan Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.